MultiStem, a stem cell treatment from Athersys, improved heart function and was well-tolerated by heart attack patients given three different dosages. The early-stage trial involved the use of a catheter to deliver the stem cells directly to damaged parts of the heart two to five days after the patient's attack.

Related Summaries